𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents

✍ Scribed by Stengel, C; Newman, S P; Leese, M P; Potter, B V L; Reed, M J; Purohit, A

Book ID
110000294
Publisher
Nature Publishing Group
Year
2009
Tongue
English
Weight
780 KB
Volume
102
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of class III ?-tubulin reduce
Expression of class III ?-tubulin reduces microtubule assembly and confers resistance to paclitaxel
✍ Hari, Malathi ;Yang, Hailing ;Zeng, Changqing ;Canizales, Martin ;Cabral, Fernan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB

## Abstract Human brain and testis specific βIII‐tubulin was amplified from a cDNA library, modified to encode a C‐terminal hemagglutinin antigen epitope tag, and cloned into a vector that allows tetracycline regulated expression in mammalian cells. Immunofluorescence analysis of transfected Chines

Tubulin targets in the pathobiology and
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β-tubulin
✍ Christos D. Katsetos; Eduarda Dráberová; Agustin Legido; Charles Dumontet; Pavel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

## Abstract Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults. Despite advances in molecular biology and genetics of gliomas currently there is no effective treatment or promising molecularly targeted experimental therapeutic strategies for these

Class III β-tubulin and the cytoskeletal
Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
✍ Marta De Donato; Marisa Mariani; Lella Petrella; Enrica Martinelli; Gian Franco 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB

## Abstract The Class III β‐tubulin isotype (βIII‐tubulin) is a predictive biomarker in ovarian cancer and other solid tumor malignancies. We discovered that βIII‐tubulin function is linked to two GTPases: guanylate‐binding protein 1 (GBP1), which activates its function, and GNAI1, which inhibits i